Assessment of Process and Outcome of Protocol-based Weaning From Mechanical Ventilation in the Medical Patients
Launched by SAMSUNG MEDICAL CENTER · Nov 19, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how patients are taken off mechanical ventilation, which is a machine that helps them breathe when they are critically ill. The researchers want to understand the process of weaning patients off this support, including how long it takes and what factors might affect the outcome. The study is taking place in a medical intensive care unit and includes adult patients who have been on mechanical ventilation for at least two days.
Anyone aged 19 and older who is receiving this type of breathing support may be eligible to participate. If you or a family member join the study, healthcare professionals will closely monitor the weaning process, gathering information about how well the patient is doing and any challenges they face. This research aims to improve how doctors manage the transition from mechanical ventilation to normal breathing, ultimately helping patients recover better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All consecutive adult patients receiving mechanical ventilation for at least two calendar days in medical intensive care units
- Exclusion Criteria:
- • None
About Samsung Medical Center
Samsung Medical Center (SMC) is a leading healthcare institution in South Korea, renowned for its commitment to advancing medical research and innovation. As a prominent clinical trial sponsor, SMC integrates cutting-edge technology and expert clinical practices to conduct rigorous studies aimed at improving patient outcomes. The center is dedicated to fostering collaborations with global research entities and adhering to the highest ethical standards, ensuring the integrity and reliability of its clinical trials. With a focus on diverse therapeutic areas, SMC plays a pivotal role in translating scientific discoveries into effective treatments, ultimately enhancing the quality of healthcare worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Kyeongman Jeon
Principal Investigator
Samsung Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials